Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program

Go back to Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
(NASDAQ: MRKR) Delayed: 1.21 --0 (-0%)
Previous Close $1.21    52 Week High
Open $1.21    52 Week Low
Day High $1.21    P/E N/A 
Day Low $1.21    EPS
Volume